In human monocytes, vitamin D suppresses the mRNA expression of Toll-like receptor 2 (Tlr-2) and Toll-like receptor 4 (Tlr-4) proteins [152], which are important regulators of metabolic inflammation during the development of metabolic disorders [153]. Here, TLR4 is linked to metabolic disease.